Received Jan 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Covid-19 vaccine (received on an unknown date) and Influenza vaccine (received on an unknown date). On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: painful). The outcome of the pain was not reported. It was unknown if the reporter considered the pain to be related to Shingrix. It was unknown if the company considered the pain to be related to Shingrix. Additional Information: GSK Receipt Date: 31-DEC-2025 This case was reported by a patient via interactive digital media. The person who gave that shot just jabbed, and never had a shot did anything like that before. The reporter would saw the medical doctor could give the shot, never had a flu or Covid shot from the hospital that was that painful. The batch number was not provided and we and unable to contact the reporter.